(Q44736087)

5 December 2017

Histamine h3 receptor antagonists potentiate methamphetamine self-administration and methamphetamine-induced accumbal dopamine release (English)

1 reference

5 December 2017

0 references

3

1 reference

5 December 2017

Gianluigi Tanda

2

0 references

author name string

Patrik Munzar

series ordinal

1

1 reference

PubMed ID

14735131

5 December 2017

Steven R Goldberg

series ordinal

4

1 reference

PubMed ID

14735131

5 December 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

5 December 2017

Neuropsychopharmacology

1 reference

5 December 2017

29

1 reference

5 December 2017

705-717

1 reference

5 December 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300380

5 December 2017

0 references

cites work

New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Histamine H(3) receptor-mediated inhibition of depolarization-induced, dopamine D(1) receptor-dependent release of [(3)H]-gamma-aminobutryic acid from rat striatal slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Highly potent and selective ligands for histamine H3-receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Methamphetamine-induced alterations in dopamine transporter function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

A single methamphetamine administration rapidly decreases vesicular dopamine uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Thioperamide, the selective histamine H3 receptor antagonist, attenuates stimulant-induced locomotor activity in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Effect of R-(-)-alpha-methylhistamine and thioperamide on in vivo release of norepinephrine in the rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell/extended amygdala dopamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

On the preferential release of dopamine in the nucleus accumbens by amphetamine: further evidence obtained by vertically implanted concentric dialysis probes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Histamine H(3) receptors depress synaptic transmission in the corticostriatal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Brainstem afferents to the tuberomammillary nucleus in the rat brain with special reference to monoaminergic innervation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Histamine H3 receptor activation selectively inhibits dopamine D1 receptor-dependent [3H]GABA release from depolarization-stimulated slices of rat substantia nigra pars reticulata.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Distribution of histamine H3-receptor binding in the normal human basal ganglia: comparison with Huntington's and Parkinson's disease cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Specificity in the projection patterns of accumbal core and shell in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Effects of histamine agents on methamphetamine-induced stereotyped behavior and behavioral sensitization in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Involvement of adenosine A1 and A2A receptors in the adenosinergic modulation of the discriminative-stimulus effects of cocaine and methamphetamine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

H3 receptor blockade by thioperamide enhances cognition in rats without inducing locomotor sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Drugs of abuse: anatomy, pharmacology and function of reward pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

4-Alkynylphenyl imidazolylpropyl ethers as selective histamine H3-receptor antagonists with high oral central nervous system activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Therapeutic potential of histamine H3 receptor agonists and antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Molecular pharmacological aspects of histamine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Histamine H3-receptor activation inhibits dopamine synthesis in rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: selective involvement of the D(2) and not D(3) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Effects of dopamine and serotonin-releasing agents on methamphetamine discrimination and self-administration in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Noradrenergic modulation of the discriminative-stimulus effects of methamphetamine in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Adenosinergic modulation of the discriminative-stimulus effects of methamphetamine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Potentiation of the discriminative-stimulus effects of methamphetamine by the histamine H3 receptor antagonist thioperamide in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Ciproxifan, a histamine H3-receptor antagonist/inverse agonist, modulates the effects of methamphetamine on neuropeptide mRNA expression in rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

A detailed autoradiographic mapping of histamine H3 receptors in rat brain areas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Modulation by dopamine receptors of the histamine release in the rat hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Neuroadaptations in the dopaminergic system after active self-administration but not after passive administration of methamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Behavioral characterization of mice lacking histamine H(3) receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Methamphetamine rapidly decreases mouse vesicular dopamine uptake: role of hyperthermia and dopamine D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

The role of reward pathways in the development of drug dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

7 January 2021

Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

7 January 2021

Cloning and functional expression of the human histamine H3 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

7 January 2021

Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

7 January 2021

Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

7 January 2021

The histamine H3 receptor and its ligands

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

7 January 2021

Inhibition of monoamine oxidase by d-methamphetamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300380

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300380

1 reference

5 December 2017

1 reference

PubMed ID

14735131